Hemoglobin-Based Oxygen Carriers: Brief History, Pharmacology and Design Strategies, Review of the Major Products in Clinical Trials, On-Going Studies, and …
JS Jahr, K Roghani, Y Buqa, A Rojhani, P Jhita… - Blood Substitutes and …, 2022 - Springer
Transfusion of erythrocytes (RBC) to treat acute or chronic anemia has significant
drawbacks, given the risks of transfusion, volunteer donor requirements, limited supply with …
drawbacks, given the risks of transfusion, volunteer donor requirements, limited supply with …
Hemoglobin-Based Oxygen Carriers: Brief History, Pharmacology and Design Strategies, Review of the Major Products in Clinical Trials, On-Going Studies, and …
JS Jahr, K Roghani, Y Buqa, A Rojhani… - Blood Substitutes …, 2022 - pesquisa.bvsalud.org
Transfusion of erythrocytes (RBC) to treat acute or chronic anemia has significant
drawbacks, given the risks of transfusion, volunteer donor requirements, limited supply with …
drawbacks, given the risks of transfusion, volunteer donor requirements, limited supply with …
Hemoglobin-Based Oxygen Carriers: Brief History, Pharmacology and Design Strategies, Review of the Major Products in Clinical Trials, On-Going Studies, and …
JS Jahr, K Roghani, Y Buqa, A Rojhani… - Blood Substitutes …, 2022 - books.google.com
Transfusion of erythrocytes (RBC) to treat acute or chronic anemia has significant
drawbacks, given the risks of transfusion, volunteer donor requirements, limited supply with …
drawbacks, given the risks of transfusion, volunteer donor requirements, limited supply with …
[引用][C] Hemoglobin-Based Oxygen Carriers: Brief History, Pharmacology and Design Strategies, Review of the Major Products in Clinical Trials, On-Going Studies, and …
JS Jahr, K Roghani, Y Buqa, A Rojhani, P Jhita… - 2022 - espace.library.uq.edu.au
Transfusion of erythrocytes (RBC) to treat acute or chronic anemia has significant
drawbacks, given the risks of transfusion, volunteer donor requirements, limited supply with …
drawbacks, given the risks of transfusion, volunteer donor requirements, limited supply with …
Hemoglobin-Based Oxygen Carriers: Brief History, Pharmacology and Design Strategies, Review of the Major Products in Clinical Trials, On-Going Studies, and …
JS Jahr, K Roghani, Y Buqa, A Rojhani… - Blood Substitutes …, 2022 - pesquisa.bvsalud.org
Transfusion of erythrocytes (RBC) to treat acute or chronic anemia has significant
drawbacks, given the risks of transfusion, volunteer donor requirements, limited supply with …
drawbacks, given the risks of transfusion, volunteer donor requirements, limited supply with …